CTHRepealedLegislation
Therapeutic Goods (Complementary Medicines—Information that Must Accompany Application for Section 26AE Listing) Determination 2018
//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Therapeutic Goods (Complementary Medicines—Information that Must Accompany Application for Section 26AE Listing) Determination 2018
Start here
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods (Complementary Medicines—Information that Must Accompany Application for Section 26AE Listing) Determination 2018.
For the purposes of subsection 23B(9) of the Act, the application must be accompanied by: (a) the information required by the document titled CTD Module 1: Administrative information for assessed listed medicines, version 1, published by the TGA in March 2018; and (b) the information required by the document titled Mandatory requirements for an effective assessed listed medicines application, version 1, published by the TGA in March 2018.
Note: The documents mentioned in section 5 are available on the TGA website (www.tga.gov.au).